Related Experiment Video
Updated: May 23, 2026
Heterokaryon Technique for Analysis of Cell Type-specific Localization
Published on: March 11, 2011
Human Gyrovirus Apoptin shows a similar subcellular distribution pattern and apoptosis induction as the chicken
J Bullenkamp1, D Cole, F Malik
1Head and Neck Oncology Group, Department of Oral Pathology, King's College London Dental Institute, Guy's Hospital Campus, London SE1 9RT, UK.
Abstract:
The chicken anaemia virus-derived protein Apoptin/VP3 (CAV-Apoptin) has the important ability to induce tumour-selective apoptosis in a variety of human cancer cells. Recently the first human Gyrovirus (HGyV) was isolated from a human skin swab. It shows significant structural and organisational resemblance to CAV and encodes a homologue of CAV-Apoptin/VP3. Using overlapping primers we constructed a synthetic human Gyrovirus Apoptin (HGyV-Apoptin) fused to green fluorescent protein in order to compare its apoptotic function in various human cancer cell lines to CAV-Apoptin. HGyV-Apoptin displayed a similar subcellular expression pattern as observed for CAV-Apoptin, marked by translocation to the nucleus of cancer cells, although it is predominantly located in the cytosol of normal human cells. Furthermore, expression of either HGyV-Apoptin or CAV-Apoptin in several cancer cell lines triggered apoptosis at comparable levels. These findings indicate a potential anti-cancer role for HGyV-Apoptin.
Insights
The human Gyrovirus Apoptin (HGyV-Apoptin) protein induces apoptosis in cancer cells, similar to the chicken anemia virus protein. This suggests HGyV-Apoptin has potential as an anti-cancer therapeutic agent.
Area of Science:
- Virology
- Molecular Biology
- Oncology
Background:
- Chicken anemia virus-derived protein Apoptin/VP3 (CAV-Apoptin) induces tumor-selective apoptosis.
- The first human Gyrovirus (HGyV) shares similarities with CAV and encodes an Apoptin homologue.
Purpose of the Study:
- To synthesize and characterize human Gyrovirus Apoptin (HGyV-Apoptin).
- To compare the apoptotic function and cellular localization of HGyV-Apoptin with CAV-Apoptin in human cancer cell lines.
Main Methods:
- Synthetic construction of HGyV-Apoptin fused to green fluorescent protein using overlapping primers.
- Expression analysis of HGyV-Apoptin and CAV-Apoptin in various human cancer and normal cell lines.
- Assessment of apoptosis induction and subcellular localization patterns.
Main Results:
- HGyV-Apoptin showed similar subcellular expression to CAV-Apoptin, translocating to the nucleus in cancer cells but remaining in the cytosol of normal cells.
- Both HGyV-Apoptin and CAV-Apoptin triggered apoptosis in cancer cell lines at comparable levels.
- HGyV-Apoptin demonstrated tumor-selective apoptosis-inducing capabilities.
Conclusions:
- HGyV-Apoptin exhibits functional and localization similarities to CAV-Apoptin.
- HGyV-Apoptin possesses potential anti-cancer properties due to its ability to induce apoptosis in cancer cells.
- This study highlights a potential new therapeutic avenue using HGyV-Apoptin for cancer treatment.
